Korsana Biosciences, Inc. Common Stock
KRSA
14 hedge funds and large institutions have $3.42M invested in Korsana Biosciences, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
4% less capital invested
Capital invested by funds: $3.58M → $3.42M (-$158K)
4.16% less ownership
Funds ownership: 43.65% → 39.49% (-4.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$374 |
| 2 |
TCP
Tyndall Capital Partners
New York
|
+$160 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$137 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$626 |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$236 |
| 3 |
Morgan Stanley
New York
|
-$22 |
KRSA Hedge Fund Activity: Q1 2024 in Review
14 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Korsana Biosciences, Inc. Common Stock (KRSA) for Q1 2024, worth a combined $3.42M — down 4.4% from $3.58M a quarter earlier.
Fund positioning in KRSA was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $374. The largest seller was Osaic Holdings, exiting entirely with an estimated $626 sold.
- 14 institutional investors held Korsana Biosciences, Inc. Common Stock (KRSA) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $3.42M of Korsana Biosciences, Inc. Common Stock stock for Q1 2024, down 4.4% quarter-over-quarter.
- 1 fund opened new Korsana Biosciences, Inc. Common Stock positions in Q1 2024 and 1 closed out, a net change of 0 holders.
- The largest Korsana Biosciences, Inc. Common Stock buyer in Q1 2024 was Geode Capital Management, an estimated $374 added.
- The largest Korsana Biosciences, Inc. Common Stock seller in Q1 2024 was Osaic Holdings, an estimated $626 sold.
Based on aggregated 13F filings for Q1 2024.